News | October 16, 2009

BIOTRONIK Home Monitoring Approved in Europe to Replace Hospital Visits

October 16, 2009 – BIOTRONIK yesterday said it recently received the Industry’s first European CE Mark approval so BIOTRONIK Home Monitoring can replace in-hospital device follow-up visits.

BIOTRONIK Home Monitoring is a wireless, mobile, remote monitoring system for patients with implantable cardiac devices. This newly authorized EU approval is based on the landmark TRUST Trial (1, 2) that proved that BIOTRONIK Home Monitoring can safely and effectively replace conventional in-hospital device follow-up visits. Patients can be remotely monitored securely through the BIOTRONIK Home Monitoring wireless system with only one annual in-clinic visit. In addition, the TRUST trial also demonstrated that BIOTRONIK Home Monitoring with its automatic daily surveillance provides early detection and notification of both symptomatic and asymptomatic arrhythmic events and device system anomalies allowing for earlier physician intervention than conventional in-hospital follow-ups.

By extending the time between routine in-hospital visits for periods up to 12 months, remote device follow-up with BIOTRONIK Home Monitoring reduces the number of physician consultations in often overburdened cardiology hospitals without negatively impacting patients’ quality of care or safety. Physicians and clinic staff benefit from reduced workloads for routine cases, which allow them to afford greater attention to patients who urgently require a consultation for diagnostics and treatment. These new approvals are applicable across the entire BIOTRONIK product portfolio of pacemakers, implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy (CRT) devices with BIOTRONIK Home Monitoring.

BIOTRONIK’s Home Monitoring technology has also just been nominated for the prestigious German Federal President’s “Deutscher Zukunftspreis” (German Innovation Award) for its pioneering achievement in medical technology.

For more information:


1. N. Varma et al. “Evaluation of efficacy and safety of remote monitoring for ICD follow-up: the TRUST trial.” Circulation 2008; 118;2309-2317, Abstract 4078.

2. N. Varma, et al, European Heart Journal 2009; 30 (Abstract Suppl.) Nr. 1909, P1656.

Related Content

AT&T Demonstrates Connectivity With Smart Scale at HIMSS 2019
News | Remote Monitoring | February 21, 2019
At the recent Healthcare Information and Management Systems Society (HIMSS) annual conference, AT&T’s healthcare...
Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote monitoring vendor Geneva Health Solutions (GHS) for implantable EP cardiac devices.

Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote monitoring vendor Geneva Health Solutions (GHS) for implantable EP cardiac devices. 

News | Remote Monitoring | February 19, 2019
Ochsner Health System in Louisiana recently announced a new partnership with device data management and remote...
Biotronik Named Exclusive U.S. Distributor of MoMe Kardia Diagnostic Monitor
News | Remote Monitoring | September 05, 2018
Biotronik announced it is now the exclusive U.S. distributor for the MoMe Kardia external cardiac diagnostic monitor...
Philips Acquires Xhale Assurance Inc.
News | Remote Monitoring | August 31, 2018
Philips announced it has acquired Xhale Assurance Inc., a U.S.-based scale-up company developing and commercializing...
The Biotricity Bioflux remote ECG monitoring system.
News | Remote Monitoring | July 24, 2018
July 24, 2018 - Diagnostic and consumer healthcare remote monitoring technology company Biotricity Inc.
LindaCare, expansion, remote patient monitoring, CIEDs, cardiac implantable electronic devices, United States
News | Remote Monitoring | January 18, 2017
LindaCare announced that it will open a new customer support facility in Connecticut to support growing interest in...
smartphone application, heart attack detection, University of Turku Finland
News | Remote Monitoring | October 28, 2016
A smartphone application developed by researchers at the University of Turku, Finland, can detect myocardial infarction...
Vital Connect, BePATIENT, BeVITAL remote monitoring system, HealthPatch MD

Vital Connect's HealthPatch MD wearable sensor, part of the BeVITAL remote monitoring system.

Technology | Remote Monitoring | June 08, 2016
Vital Connect Inc., developer of wearable biosensor technologies, and BePATIENT, a startup that develops patient-...
Ambio Health telemonitoring system, LifeBridge Health Cardiovascular Institute, Baltimore, pilot study
News | Remote Monitoring | May 26, 2016
The LifeBridge Health Cardiovascular Institute, Baltimore, has launched a pilot study to evaluate the potential...
Biotronik, BioMonitor 2, AF remote monitoring, atrial fibrillation, U.K. and Ireland
News | Remote Monitoring | March 14, 2016
Biotronik announced that its BioMonitor 2 heart monitor is now available for patients in the United Kingdom. The...
Overlay Init